Drugs for Intestinal Obstruction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 134)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Dexmedetomidine |
Approved, Experimental, Vet_approved |
Phase 4 |
|
86347-14-0, 113775-47-6 |
68602 5311068 |
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
(+-)-4-(a,2,3-Trimethylbenzyl)imidazole
(+-)-4-(alpha,2,3-Trimethylbenzyl)imidazole
(+-)-4-(Α,2,3-trimethylbenzyl)imidazole
(+)-MEDETOMIDINE
(±)-4-(α,2,3-trimethylbenzyl)imidazole
(S)-MEDETOMIDINE
Dexdor
Dexdor®|Igalmi® (dexmedetomidine sublingual film)|MPV 1440|Precedex®
DEXMEDETOMIDIN
Dexmedetomidina
DEXMEDETOMIDINE
DEXMÉDÉTOMIDINE
Dexmedetomidine hydrochloride
Dexmedetomidinum
|
Domitor
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Hydrochloride, medetomidine
Levomedetomidine
Medetomidina
Medetomidina [Spanish]
Medetomidine
Medetomidine hydrochloride
Medetomidinum
Medetomidinum [Latin]
MPV 1440
MPV 785
MPV-1440
MPV-785
Precedex
|
|
2 |
|
Benzocaine |
Approved, Investigational |
Phase 4 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
3 |
|
Tannic acid |
Approved |
Phase 4 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
4 |
|
Propofol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2078-54-8 |
4943 |
Synonyms:
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Diisopropylphenol
2,6-diisopropylphenol|Diprivan®|ICI 35868
Abbott brand OF propofol
Alpha Brand OF propofol
Aquafol
Astra brand OF propofol
AstraZeneca brand OF propofol
Braun brand OF propofol
Curamed brand OF propofol
Diisopropylphenol
Diprivan
Disoprivan
Disoprofol
Fresenius brand OF propofol
Fresenius kabi brand OF propofol
Fresofol
ICI 35868
ICI 35-868
|
ICI35,868
ICI-35868
Ivofol
Juste brand OF propofol
NSC-5105
Parnell brand OF propofol
Pisa brand OF propofol
Propofol
Propofol abbott
Propofol fresenius
Propofol MCT
Propofol rovi
Propofol-lipuro
Propofolum
Rapinovet
Recofol
Rovi brand OF propofol
Schering brand OF propofol
Zeneca brand OF propofol
|
|
5 |
|
Ketamine |
Approved, Vet_approved |
Phase 4 |
|
6740-88-1, 1867-66-9 |
3821 |
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(O-Chlorophenyl)-2-(methylamino)-cyclohexanone
Calipsol
Calypsol
CI 581 base
CLSTA 20
DL-Ketamine
Esketamine
Kalipsol
Ketaject
Ketalar
|
Ketalar base
Ketalar|ketamine HCl
Ketamina
KETAMINE
Kétamine
Ketamine base
Ketamine HCL
Ketamine hydrochloride
Ketaminum
Ketanest
Ketaset
Ketolar
L-Ketamine
NMDA
NSC-70151
Special K
Tekam
|
|
6 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290 |
Synonyms:
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Esmeron
Esmerone
ORG-9426
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
|
Rocuronio
ROCURONIUM
Rocuronium bromide
Zemuron
|
|
7 |
|
Somatostatin |
Approved, Investigational |
Phase 4 |
|
38916-34-6, 51110-01-1 |
53481605 16129706 |
Synonyms:
(5S,8R,14R,17R,20R,23R,26R,29R,32R,35R)-38-[(2-{[(2R)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-20,35-bis(4-aminobutyl)-14,26,29-tribenzyl-7,10,13,16,19,22,25,28,31,34,37-undecahydroxy-32-[(C-hydroxycarbonimidoyl)methyl]-11-(1-hydroxyethyl)-17-[(1S)-1-hydroxyethyl]-8-(hydroxymethyl)-23-[(1H-indol-3-yl)methyl]-1,2-dithia-6,9,12,15,18,21,24,27,30,33,36-undecaazacyclononatriaconta-6,9,12,15,18,21,24,27,30,33,36-undecaene-5-carboxylate
ALA-GLY-CYCLO-[CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS]
Growth hormone-inhibiting hormone (ghih)
L-ALANYLGLYCYL-L-CYSTEINYL-L-LYSYL-L-ASPARAGINYL-L-PHENYLALANYL-L-PHENYLALANYL-L-TRYPTOPHYL-L-LYSYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-CYSTEINE CYCLIC (3-14) DISULFIDE
SOMATOSTATIN
SOMATOSTATIN-1
SOMATOSTATIN-14
SOMATOSTATINA
|
SOMATOSTATINE
SOMATOSTATINUM
Somatotropin release-inhibiting factor (srif)
Somatotropin release-inhibiting hormone
SRIF-14
SYNTHETIC GROWTH HORMONE RELEASE-INHIBITING HORMONE
SYNTHETIC SOMATOSTATIN-14
|
|
8 |
|
Bupivacaine |
Approved, Investigational |
Phase 4 |
|
2180-92-9, 38396-39-3 |
2474 |
Synonyms:
(+-)-Bupivacaine
(±)-bupivacaine
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
Abbott brand OF bupivacaine hydrochloride
ANEKAIN
Anhydrous, bupivacaine
Astra brand OF bupivacaine hydrochloride
AstraZeneca brand OF bupivacaine hydrochloride
Aventis brand OF bupivacaine hydrochloride
Bloqueina
Braun brand OF bupivacaine hydrochloride
Braun, bupivacaina
Bucaine
Bupivacain janapharm
Bupivacain RPR
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaina braun
BUPIVACAINE
Bupivacaine anhydrous
Bupivacaine carbonate
Bupivacaine HCL
Bupivacaine HCL kit
Bupivacaine hydrochloride
Bupivacaine monohydrochloride, monohydrate
Bupivacain-RPR
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
Buvacaina
|
Carbonate, bupivacaine
Carbostesin
CBupivacaine
Chirocaine
DepoBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
DL-Bupivacaine|Exparel®|Marcain®|Posimir®|Sensorcaine®|W-7|Xaracoll®
Dolanaest
DUR-843
Exparel
Hydrochloride, bupivacaine
Inibsa brand OF bupivacaine hydrochloride
Janapharm, bupivacain
Jenapharm brand OF bupivacaine hydrochloride
LAC-43
LIQ865
LIQ-865
Marcain
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
Pisa brand OF bupivacaine hydrochloride
Racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SKY-0402
Strathmann brand OF bupivacaine hydrochloride
Svedocain sin vasoconstr
Transdur-Bupivacaine
|
|
9 |
|
Ketorolac |
Approved |
Phase 4 |
|
74103-06-3, 66635-83-4 |
3826 |
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
ACULAR
Acular LS
Acular Preservative Free
Acular®|Toradol®
Ketoralac
Ketorolac
|
Kétorolac
Ketorolac tromethamine
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
rac-Ketorolac
Toradol
|
|
10 |
|
Morphine |
Approved, Investigational |
Phase 4 |
|
57-27-2 |
5288826 |
Synonyms:
(-)-Heroin hydrochloride
(-)-Morphine
(−)-MORPHINE
(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5a,6a)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5Α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5Α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
ANHYDROUS MORPHINE
Apokyn
Astramorph PF
AVINZA
Chloride, morphine
Contin, MS
D-(-)-Morphine
DEPODUR
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dulcontin
Duramorph
Duramorph PF
Duromorph
Epimorph
Heroin hydrochloride
Heroine hydrochloride
IDS-NM-009
INFUMORPH
KADIAN
l-Morphine
M.O.S
Meconium
M-Eslon
Morfina
Morfina dosa
|
Morphia
Morphin
Morphina
MORPHINE
Morphine chloride
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine sulfate
Morphine sulfate (2:1), anhydrous
Morphine sulfate (2:1), pentahydrate
morphine sulfate|Ms Contin®|Oramorph®
Morphinism
Morphinum
Morphitec
Morphium
Moscontin
MS Contin
MS/L
MS/S
MSIR
N02AA01
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
ORAMORPH
Oramorph SR
Ospalivina
Rescudose
RMS Uniserts
Roxanol
Roxanol 100
Roxanol UD
Statex
Statex Drops
Substitol
Sulfate, morphine
|
|
11 |
|
Adrenergic alpha-Agonists |
|
Phase 4 |
|
|
|
12 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
13 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
14 |
|
Anesthetics, Intravenous |
|
Phase 4 |
|
|
|
15 |
|
Anesthetics, General |
|
Phase 4 |
|
|
|
16 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
17 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
18 |
|
Hormones |
|
Phase 4 |
|
|
|
19 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
20 |
|
Excitatory Amino Acid Antagonists |
|
Phase 4 |
|
|
|
21 |
|
Anesthetics, Dissociative |
|
Phase 4 |
|
|
|
22 |
|
Neuromuscular Nondepolarizing Agents |
|
Phase 4 |
|
|
|
23 |
|
Neuromuscular Blocking Agents |
|
Phase 4 |
|
|
|
24 |
|
Anesthetics |
|
Phase 4 |
|
|
|
25 |
|
Analgesics |
|
Phase 4 |
|
|
|
26 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
27 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
28 |
|
Narcotics |
|
Phase 4 |
|
|
|
29 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
30 |
|
Analgesics, Opioid |
|
Phase 4 |
|
|
|
31 |
|
Naloxone |
Approved, Vet_approved |
Phase 3 |
|
465-65-6 |
5284596 |
Synonyms:
(-)-Naloxone
(−)-NALOXONE
(-)-naloxone|Kloxxado® (naloxone hydrochloride nasal spray)|l-naloxone|Narcan®|Nyxoid®
[<i>N</i>-allyl-2,3-<sup>3</sup>H]naloxone
17-Allyl-3,14-dihydroxy-4,5a-epoxymorphinan-6-one
17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
17-Allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one
1-N-Allyl-14-hydroxynordihydromorphinone
Abello brand OF naloxone hydrochloride
Abello, naloxone
Boots brand OF naloxone hydrochloride
Bristol myers squibb brand OF naloxone hydrochloride
Bristol-myers squibb brand OF naloxone hydrochloride
Curamed brand OF naloxone hydrochloride
Curamed, naloxon
DBL Naloxone
Dihydride, naloxone hydrochloride
EN 1530 base
endo Brand OF naloxone hydrochloride
Hydrobromide, naloxone
Hydrochloride dihydride, naloxone
Hydrochloride, naloxone
Lamepro brand OF naloxone hydrochloride
L-Naloxone
MRZ 2593 BR
MRZ 2593BR
MRZ 2593-BR
N-Allylnoroxymorphone
|
Nalone
Nalossone
Nalossone [Dcit]
Naloxon curamed
Naloxon ratiopharm
Naloxona
Naloxona [INN-Spanish]
NALOXONE
Naloxone abello
Naloxone HCl
Naloxone hydrobromide
Naloxone hydrochloride
Naloxone hydrochloride dihydride
Naloxone hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-isomer
Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-isomer
Naloxonratiopharm
Naloxon-ratiopharm
Naloxonum
Naloxonum [INN-Latin]
Narcan
Narcanti
Narcon
NSC-70413
Ratiopharm brand OF naloxone hydrochloride
SERB brand OF naloxone hydrochloride
SUBOXONE
United drug brand OF naloxone hydrochloride
|
|
32 |
|
Lanreotide |
Approved |
Phase 3 |
|
108736-35-2 |
71349 6918011 |
Synonyms:
188Re-Lanreotide
2-{[(19-{[2-amino-1-hydroxy-3-(naphthalen-2-yl)propylidene]amino}-10-(4-aminobutyl)-6,9,12,15,18-pentahydroxy-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaen-4-yl)(hydroxy)methylidene]amino}-3-hydroxybutanimidate
2-Naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide
BIM 23014
BIM 23014|DC 13-116|lanreotide acetate|Somatuline®
DC 13-116
Lanreotida
Lanreotide
Lanreotide acetate
Lanreotide acetic acid
Lanreotide-SR
|
L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
Nal-cyclo(cys-tyr-TRP-lys-val-cys)THR-NH2
Nal-cyclo(cys-tyr-TRP-lys-val-cys)-THR-NH2
Naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide
Naphthyl-cyclo(cys-tyr-TRP-lys-val-cys)THR-NH2
Somatulin
Somatulina
Somatuline
SOMATULINE AUTOGEL
SOMATULINE LA
|
|
33 |
|
Phenobarbital |
Approved, Investigational |
Phase 3 |
|
50-06-6 |
4763 |
Synonyms:
5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenylbarbitate
5-Ethyl-5-phenylbarbitic acid
5-Ethyl-5-phenylbarbituric acid
5-Ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione
5-Phenyl-5-ethylbarbitate
5-Phenyl-5-ethylbarbitic acid
5-Phenyl-5-ethylbarbituric acid
Acid, phenylethylbarbituric
Adonal
Aephenal
Agrypnal
Amylofene
Aphenylbarbit
Aphenyletten
Barbenyl
Barbinal
Barbiphen
Barbiphenyl
Barbipil
Barbita
Barbivis
Barbonal
Barbophen
Bardorm
Bartol
Bialminal
Blu-Phen
Cabronal
Calmetten
Calminal
Cardenal
Chinoin
Codibarbita
Coronaletta
Cratecil
Damoral
Dezibarbitur
Dormina
Dormiral
Dormital
Doscalun
Duneryl
Ensobarb
Ensodorm
Epanal
Epidorm
Epilol
Episedal
Epsylone
ESKABARB
Etilfen
Euneryl
Fenbital
Fenemal
Fenobarbital
fenobarbital|Luminal®|phenobarb|phenobarbital sodium|phenobarbitone|phenylethylbarbiturate
Fenosed
Fenylettae
Gardenal
Gardepanyl
Glysoletten
Haplopan
Haplos
Helional
Hennoletten
Henotal
Hypnaletten
Hypnette
Hypnogen
Hypnolone
Hypnoltol
Hypno-Tablinetten
Hysteps
Lefebar
Leonal
Lephebar
Lepinal
Lepinaletten
Linasen
Liquital
Lixophen
Lubergal
Lubrokal
Lumen
Lumesettes
|
Lumesyn
Luminal
Lumofridetten
Luphenil
Luramin
Molinal
Monosodium salt phenobarbital
Neurobarb
Nirvonal
NOPTIL
Nova-Pheno
NSC-128143
NSC-128143-
NSC-9848
Nunol
Parkotal
Pharmetten
Phenaemal
Phen-Bar
Phenemal
Phenemalum
Phenobal
PHENOBARBITAL
PHENOBARBITAL CIV
Phenobarbital sodium
Phenobarbital, monosodium salt
Phenobarbitate
Phenobarbitic acid
Phenobarbitol
Phenobarbitone
Phenobarbituric acid
Phenobarbyl
Phenoluric
Phenolurio
Phenomet
Phenonyl
Phenoturic
Phenylaethylbarbitursaeure
Phenyläthylbarbitursäure
Phenylbarbital
Phenylethylbarbitate
Phenylethylbarbitic acid
Phenylethylbarbiturate
Phenylethylbarbituric acid
Phenylethylbarbitursaeure
Phenylethylbarbitursäure
PHENYLETHYLMALONYLUREA
Phenyletten
Phenyral
Phob
Polcominal
Promptonal
Sedabar
Seda-Tablinen
Sedicat
Sedizorin
Sedlyn
Sedofen
Sedonal
Sedonettes
Sevenal
Sinoratox
Sodium, phenobarbital
SOLFOTON
Solfoton Talpheno
Solu-Barb
Sombutol
Somnolens
Somnoletten
Somnosan
Somonal
Spasepilin
Starifen
Starilettae
Stental
Stental Extentabs
TALPHENO
Teolaxin
Teoloxin
Thenobarbital
Theoloxin
Triabarb
Tridezibarbitur
Triphenatol
Versomnal
Zadoletten
Zadonal
|
|
34 |
|
Metronidazole |
Approved |
Phase 3 |
|
443-48-1, 69198-10-3 |
4173 |
Synonyms:
1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(b-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(b-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(b-Oxyethyl)-2-methyl-5-nitroimidazole
1-(Β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(Β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(Β-oxyethyl)-2-methyl-5-nitroimidazole
2 Methyl 5 nitroimidazole 1 ethanol
2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-5-nitroimidazole-1-ethanol
ACEA
Acromona
ANABACT
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAY-5360
Bayer 5360
BAYER-5360
Bexon
Clont
Cont
Danizol
Deflamon
Deflamon-Wirkstoff
DRAZIFON
Efloran
ELYZOL
Entizol
Eumin
Flagemona
Flagesol
Flagil
Flagyl
FLAGYL 375
FLAGYL COMPAK
FLAGYL ER
Flagyl I.V.
FLAGYL I.V. RTU IN PLASTIC CONTAINER
FLAGYL-400
FLAGYL-S
Flegyl
Fossyol
Giatricol
Gineflavir
Hydrochloride, metronidazole
Klion
Klont
Meronidal
Methronidazole
Metric
METRIC 21
Metro Cream
Metro I.V.
Metro I.V. In Plastic Container
METRO IV
METROCREAM
Metrodzhil
MetroGel
Metrogel-vaginal
Metrogyl
Metrolag
METROLOTION
METROLYL
|
METROMIDOL
Metronidaz
Metronidazol
METRONIDAZOLE
Métronidazole
Metronidazole benzoate
Metronidazole Hcl
Metronidazole hydrochloride
Metronidazole in plastic container
Metronidazole monohydrochloride
Metronidazole phosphate
Metronidazole phosphoester
Metronidazolo
Metronidazolum
METROSA
METROTOP
Mexibol
Monagyl
Monasin
Monohydrochloride, metronidazole
Nalox
Neo-Tric
NEUTRATOP
Nida
Nidagel
Noritate
Noritic acid
NORZOL
Novonidazol
NSC-50364
NSC-69587
NUVESSA
Orvagil
Phosphate, metronidazole
Phosphoester, metronidazole
PROTOSTAT
Rathimed
ROSICED
ROZEX
RP-8823
Sanatrichom
Satric
Takimetol
Trichazol
Trichex
Tricho Cordes
Trichocide
Tricho-Gynaedron
Trichomol
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
Vagilen
Vagimid
VAGINYL
VANDAZOLE
Vertisal
Wagitran
ZADSTAT
ZIDOVAL
ZYOMET
|
|
35 |
|
Amoxicillin |
Approved, Vet_approved |
Phase 3 |
|
26787-78-0 |
33613 |
Synonyms:
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(p-Hydroxy-a-aminophenylacetamido)penicillanate
6-(p-Hydroxy-a-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanate
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-α-aminophenylacetamido)penicillanate
6-(p-Hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9ci
a-Amino-p-hydroxybenzylpenicillin
Actimoxi
Almodan
alpha-Amino-p-hydroxybenzylpenicillin
AMC
Amix
AMIX 125
AMIX 250
AMIX 500
Amoclen
Amolin
Amopen
Amopenixin
Amoram
AMOX
Amox 250 cap 250MG
Amox 500 cap 500MG
Amox S 125 sus 125mg/5ML
Amox S 250 sus 250mg/5ML
Amoxi
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (anhydrous)
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin clariana brand
AMOXICILLIN HYDRATE
Amoxicillin monopotassium salt
Amoxicillin monosodium salt
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicillin, (r*)-isomer
Amoxicilline
Amoxicilline [INN-French]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
AMOXIDENT 250
AMOXIDENT 500
AMOXI-INJECT
Amoxil
AMOXIL FIZTAB
AMOXIL SF
Amoxi-mast
AMOXI-TABS
Amoxivet
Amoxycilin
Amoxycillin
AMOXYCILLIN ANHYDROUS
Amoxycillin trihydrate
Amoxycillin, ban
Amoxymed
AMPC
Amrit
Anemolin
Anhydrous, amoxicillin
Apo-amoxi
Apo-amoxi cap 250MG
Apo-amoxi cap 500MG
Apo-amoxi PWR for susp 125mg/5ML
Apo-amoxi PWR for susp 250mg/5ML
Apo-amoxi sugar free
AQUACIL
Aspenil
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
|
AUGMENTIN '875'
AUGMENTIN es-600
AX
Biomox
Bristamox
BRL 2333
BRL-2333
Cemoxin
Clamoxyl
Clamoxyl (SKB)
Clamoxyl g.a.
Clamoxyl parenteral
Clariana brand OF amoxicillin
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
DEDOXIL
Delacillin
Dispermox
Efpenix
Flemoxin
FLEMOXIN SOLUTAB
G.A., clamoxyl
Galenamox
Gen-amoxicillin 250MG
Gen-amoxicillin 500MG
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
Lamoxy
Larotid
Metafarma capsules
Metifarma capsules
Moxacin
Moxal
Moxatag
Novamoxin cap 250MG
Novamoxin cap 500MG
Novamoxin sus 125mg/5ML
Novamoxin sus 250mg/5ML
NSC-277174
Nu-amoxi cap 250MG
Nu-amoxi cap 500MG
Nu-amoxi sus 125/5ML
Nu-amoxi sus 250mg/5ML
Ospamox
Pamoxicillin
Parenteral, clamoxyl
Penamox
Pfizer brand OF amoxicillin sodium salt
PHL-Amoxicillin
p-Hydroxyampicillin
Piramox
PMS-Amoxicillin
Polymox
Prevpac
Pro amox PWR for oral susp 125mg/5ML
Pro amox-250 cap 250MG
Pro amox-500 cap 500MG
Pro-amox-250 orl sus 250mg/5ML
RESPILLIN
R-Hydroxyampicillin
Rimoxallin
Robamox
Sauracillin
Sawamox PM
SmithKline beecham brand OF amoxicillin sodium salt
Sodium, amoxicillin
Sumox
Tolodina
Trihydrate, amoxicillin
Trimox
Unicillin
Utimox
Vetramox
VETREMOX
Wymox
Zimox
ZOXYCIL 250
ZOXYCIL 500
Α-amino-p-hydroxybenzylpenicillin
|
|
36 |
|
Cefuroxime |
Approved |
Phase 3 |
|
55268-75-2 |
5479529 |
Synonyms:
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
640/359
ANAPTIVAN
CEFTIN
Cefuroxim
Cefuroxima
CEFUROXIME
CEFUROXIMINE
Cefuroximo
|
Cefuroximum
Cephuroxime
CXM
KEFUROS
KEFUROX
Ketocef
Sharox
XIMOS
Zinacef
Zinacef danmark
|
|
37 |
|
Fluconazole |
Approved, Investigational |
Phase 3 |
|
86386-73-4 |
3365 |
Synonyms:
2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol
2,4-Difluoro-a,a-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-Difluoro-α,α-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
AbZ brand OF fluconazole
Aliud brand OF fluconazole
Alpharma brand OF fluconazole
Apo fluconazole
Apo-fluconazole
Apotex brand OF fluconazole
Armstrong brand OF fluconazole
Béagyne
Betapharm brand OF fluconazole
Biozole
CANESTEN ORAL
Chemia brand OF fluconazole
CT Arzneimittel brand OF fluconazole
CT-Arzneimittel brand OF fluconazole
Diflucan
DIFLUCAN IN SODIUM CHLORIDE
DIFLUCAN ONE
Difluconazole
Effik brand OF fluconazole
Elazor
Fluc hexal
Flucobeta
FlucoLich
Fluconazol
Fluconazol abz
Fluconazol al
Fluconazol isis
|
Fluconazol ratiopharm
Fluconazol stada
Fluconazol von CT
Fluconazole
Fluconazole capsules
FLUCONAZOLE IN SODIUM CHLORIDE
Fluconazol-isis
Fluconazol-ratiopharm
Fluconazolum
Flunazul
Fungata
Hexal brand OF fluconazole
Lavisa
Lesvi brand OF fluconazole
Lichtenstein brand OF fluconazole
Loitin
Mack brand OF fluconazole
Neofomiral
Oxifungol
Pfizer brand OF fluconazole
Pfleger brand OF fluconazole
Ratiopharm brand OF fluconazole
SAT brand OF fluconazole
Silanes brand OF fluconazole
Solacap
Stada brand OF fluconazole
Triflucan
UK-49858
Vita brand OF fluconazole
Zonal
|
|
38 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 3 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
39 |
|
Clavulanic acid |
Approved, Vet_approved |
Phase 3 |
|
58001-44-8 |
5280980 |
Synonyms:
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylate
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
Acide clavulanique
Acido clavulanico
ácido clavulánico
Acidum clavulanicum
Antibiotic MM 14151
BRL-14151
Clavulanate
Clavulanate potassium
Clavulanate, potassium
Clavulanate, sodium
|
Clavulanic acid
Clavulanic acid, monopotassium salt
Clavulanic acid, monosodium salt
Clavulansaeure
Clavulansäure
Clavulonate
Clavulonic acid
Clavulox
CVA
MM 14151
Potassium clavulanate
Potassium, clavulanate
RX-10100
Sodium clavulanate
|
|
40 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 3 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
41 |
|
Narcotic Antagonists |
|
Phase 3 |
|
|
|
42 |
|
Antibiotics, Antitubercular |
|
Phase 3 |
|
|
|
43 |
|
Anti-Bacterial Agents |
|
Phase 3 |
|
|
|
44 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
45 |
|
Anticonvulsants |
|
Phase 3 |
|
|
|
46 |
|
GABA Modulators |
|
Phase 3 |
|
|
|
47 |
|
Antiprotozoal Agents |
|
Phase 3 |
|
|
|
48 |
|
Antiparasitic Agents |
|
Phase 3 |
|
|
|
49 |
|
Cefuroxime axetil |
|
Phase 3 |
|
|
3379942 |
Synonyms:
Acetoxyethylcefuroxime
Ceftin
|
Cefuroxime 1-acetoxyethyl ester
Zinnat
|
|
50 |
|
beta-Lactamase Inhibitors |
|
Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 117)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Ketofol vs Dexmedetomidine for Preventing Post-operative Delirium in Elderly Patients Undergoing Intestinal Obstruction Surgeries. A Randomized Controlled Study |
Completed |
NCT04816162 |
Phase 4 |
ketofol;dexmedetomidine |
2 |
Phase 4 Evaluation of SurgiWrapTM to Minimize Soft Tissue Attachment & Reduce the Incidence of Early Post-Operative Bowel Obstruction in Colorectal Surgery |
Completed |
NCT00531739 |
Phase 4 |
|
3 |
Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction |
Completed |
NCT00389116 |
Phase 4 |
gastrograffin;water |
4 |
Gastrografin Use in Small Bowel Obstruction Caused by Adherences |
Completed |
NCT00601809 |
Phase 4 |
Gastrografin®: G |
5 |
Effect of Deep Versus Moderate Neuromuscular Blockade on Peak Airway Pressures During Elective Laparoscopic Surgery |
Completed |
NCT02812186 |
Phase 4 |
Rocuronium |
6 |
Prospective, Multi-centers, Investigator Sponsored, Randomized Controlled Trial Towards Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction |
Completed |
NCT01082627 |
Phase 4 |
Somatostatin |
7 |
A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy |
Completed |
NCT01507246 |
Phase 4 |
IV morphine sulfate;EXPAREL (bupivacaine liposome injectable suspension) |
8 |
The Effects of Preoperative High-dose Dexamethasone on Inflammatory Response and Recovery After Emergency Laparotomy, a Randomized, Double-blind, Placebo-controlled Clinical Trial - AHA STEROID TRIAL |
Recruiting |
NCT04791566 |
Phase 4 |
Dexamethasone 1 mg/kg;Physiologic saline |
9 |
A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation of Bupivacaine, EXPAREL(R): A Phase 4 Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy (IMPROVE-Lap Colectomy) |
Terminated |
NCT02058290 |
Phase 4 |
IV morphine sulfate or Sponsor-approved equivalent;EXPAREL |
10 |
A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy |
Terminated |
NCT01507233 |
Phase 4 |
IV morphine sulfate;EXPAREL (bupivacaine liposome injectable suspension) |
11 |
A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy |
Terminated |
NCT01507220 |
Phase 4 |
morphine sulfate;bupivacaine liposome extended-release injectable suspension |
12 |
The Use of Gastrografin to Help Alleviate Bowel Obstruction Related to Poor Bowel Motility in Gastroschisis Patients. |
Withdrawn |
NCT03334578 |
Phase 4 |
Gastrografin |
13 |
Prospective Multicenter Trial for Anti-adhesion Effect of GUARDIX-SGⓇ Following Radical Gastrectomy in Patients With Gastric Cancer. |
Unknown status |
NCT02198898 |
Phase 3 |
|
14 |
Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers: A Randomised Trial |
Unknown status |
NCT00164879 |
Phase 3 |
|
15 |
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase IIB Study of Oral Naloxone for the Treatment of Opioid-Induced Constipation in Patients With Chronic, Non-malignant Pain or Malignant Pain |
Unknown status |
NCT00020605 |
Phase 3 |
naloxone hydrochloride |
16 |
Effects of Delayed Enteral Nutrition on Inflammatory Responses and Immune Function Competence in Critically Ill Patients With Prolonged Fasting |
Completed |
NCT01834430 |
Phase 3 |
|
17 |
Endoscopic Stenting and Elective Surgery Versus Emergency Surgery for Left-sided Malignant Colonic Obstruction: A Prospective Randomized Trial. |
Completed |
NCT00758186 |
Phase 3 |
|
18 |
Phase III, Multicentre, Randomised, Double-blind, Comparative Study to Assess the Efficacy and Safety of Lanreotide 30 mg Versus Placebo as a Palliative Treatment of Clinical Symptoms Associated With Intestinal Obstruction Due to Peritoneal Carcinomatosis in Inoperable Patients. |
Completed |
NCT00216372 |
Phase 3 |
Lanreotide (microparticle formulation) |
19 |
Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction in Patients With Gastric Cancer. A Randomized Clinical Trial |
Completed |
NCT00529412 |
Phase 3 |
|
20 |
Outcome of Palliative Management of Malignant Large Bowel Obstruction With Colorectal Stents or Surgery |
Completed |
NCT00140868 |
Phase 3 |
|
21 |
Phase 3 Study of Antibiotic Prophylaxis Use Prior Emergent Surgery, Because of Acute Appendicitis |
Completed |
NCT01524081 |
Phase 3 |
Metronidazole, Cefuroxime;Amoxicillin (+ clavulanic acid) and Fluconazole;Placebo |
22 |
The Therapeutic Role of Gastrografin for Treating Small Bowel Obstruction in Children: A Multi-Centre Canadian Prospective Study |
Recruiting |
NCT03573921 |
Phase 2, Phase 3 |
Gastrografin |
23 |
A Phase III, Randomized, Double-Blind Placebo Controlled Study of the Probiotic Preparation VSL#3® Versus Placebo in the Prevention of Acute Enteritis in Patients Receiving Concurrent Chemotherapy and Pelvic Radiation Therapy |
Withdrawn |
NCT01473290 |
Phase 3 |
|
24 |
An International, Multicentric, Prospective, Open Label Study to Assess the Efficacy and Safety of Lanreotide Autogel 120 MG Associated to Standard of Care in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction |
Completed |
NCT02275338 |
Phase 2 |
Lanreotide Autogel |
25 |
Evaluation of the Effect of Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis |
Completed |
NCT00332696 |
Phase 2 |
Octreotide LAR;Octreotide (Immediate release);methylprednisolone;Placebo |
26 |
Prospective Study to Assess the Efficacy and Safety of Lanreotide 120 mg as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients |
Completed |
NCT01076803 |
Phase 2 |
Lanreotide (acetate) |
27 |
Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study |
Completed |
NCT00004895 |
Phase 2 |
octreotide acetate |
28 |
A Pilot Phase I/II Trial of Enteral Wallstents for Colonic Obstruction in the Setting of Malignancy |
Completed |
NCT00004911 |
Phase 1, Phase 2 |
|
29 |
A Pilot Phase I/II Trial of Enteral Wallstents for Duodenal Obstruction in the Setting of Malignancy |
Completed |
NCT00004910 |
Phase 1, Phase 2 |
|
30 |
A Phase II, Non-Randomized, Multi-Cohort Trial of Docetaxel, Oxaliplatin and 5-Fluorouracil in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis and Inoperable Malignant Bowel Obstruction |
Recruiting |
NCT04840264 |
Phase 2 |
Docetaxel;Oxaliplatin;5Fluorouracil |
31 |
A Phase II, Multicentre, Randomized Controlled Study Evaluating The Quality Of Life In Patients With Inoperable Malignant Bowel Obstruction Treated With Lanreotide Autogel 120 mg in Combination With Standard Care vs. Standard Care Alone (QOL IN IMBO STUDY) |
Terminated |
NCT02365584 |
Phase 2 |
lanreotide (Autogel formulation) |
32 |
Prospective, Randomized Trial Comparing Early Laparoscopic Enterolysis Versus a Time-limited Trial of Nonoperative Management for High-grade Small Bowel Obstruction |
Terminated |
NCT02692638 |
Phase 2 |
|
33 |
Palliative Management of Inoperable Malignant Bowel Obstruction: A Prospective, Open Label, Phase-2 Study at an NCI Comprehensive Cancer Center |
Terminated |
NCT04027348 |
Phase 2 |
Dexamethasone;Metoclopramide;Octreotide |
34 |
Phase I/II Trial of Best Supportive Care and Chemotherapy, Either Cisplatin or Paclitaxel, in Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer Presenting With Inoperable Malignant Bowel Obstruction |
Terminated |
NCT01083537 |
Phase 1, Phase 2 |
Cisplatin;Paclitaxel |
35 |
Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects |
Completed |
NCT01596777 |
Phase 1 |
Loperamide;Loperamide placebo;Methylnaltrexone placebo;Methylnaltrexone 12 mg sc.;Methylnaltrexone IR capsule;Methylnaltrexone ER capsule;Sulfasalazine |
36 |
Effects of Extended Release Methylnaltrexone Bromide (150 mg b.i.d.) in Comparison to Extended Release Naloxone Hydrochloride (20 mg b.i.d.) on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time in Healthy Subjects. |
Completed |
NCT01596764 |
Phase 1 |
Loperamide placebo;Loperamide;Sulfasalazine;Placebo of MNTX and NLX;Naloxone;Methylnaltrexone |
37 |
Therapeutic Oxygen for Gastrointestinal Atony (TOGA): Pilot Trial - Management of Acute Colonic Pseudo-Obstruction With Oxygen Supplementation |
Completed |
NCT03386136 |
Phase 1 |
100% Oxygen |
38 |
Hypertonic Saline 3% Compared to Hypertonic Saline 1.8% for Fluid Management of Intestinal Obstruction Surgery |
Unknown status |
NCT03741257 |
|
Hypertonic saline |
39 |
Ostomy in Continuity or Conventional Ileostomy for Complex Pediatric Intestinal Diseases: a Retrospective Multicentric Analysis |
Unknown status |
NCT04213976 |
|
|
40 |
Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients |
Unknown status |
NCT01669044 |
|
dexmedetomidine;propofol |
41 |
Prospective Multicenter Validation of a Clinicoradiological Score for Predicting the Severity of Strangulated Small Bowel Occlusion |
Unknown status |
NCT01125280 |
|
|
42 |
The Impact of Small Bowel Obstruction (SBO) on Quality of Life (QOL); the Efficacy of a Manual Physical Therapy to Improve QOL in Subjects With a History of SBO |
Unknown status |
NCT02639195 |
|
|
43 |
The BCAE Study: Best Care for Abdominal Emergencies |
Unknown status |
NCT04577339 |
|
|
44 |
Colonic Stenting With Elective Surgery Versus Emergency Surgery in the Management of Acute Malignant Colonic Obstruction: a Multicentre, Prospective, Open Label, Cohort Study |
Unknown status |
NCT01997684 |
|
|
45 |
Prospective Nationwide Audit of the Management of Adhesive Small Bowel Obstruction: a Snapshot Study |
Unknown status |
NCT03786159 |
|
|
46 |
Intrabdominal Pressure in Small Bowel Obstruction as a Possible Predictor for the Need of Operation |
Unknown status |
NCT01934283 |
|
|
47 |
Laparoscopic Versus Open Adhesiolysis for Small Bowel Obstruction - A Multicenter, Prospective, Randomized, Controlled Trial |
Unknown status |
NCT01867528 |
|
|
48 |
A Feasibility Study of Elemental Diet as an Alternative to Parenteral Nutrition for Patients With Inoperable Malignant Bowel Obstruction |
Unknown status |
NCT03150992 |
|
|
49 |
Nasogastric Tube Clamping Trial: Is it Useful? A Proposed Algorithm for Removal. |
Unknown status |
NCT04001985 |
|
|
50 |
Ultrasound Emergency Diagnosis of Small Bowel Obstruction. An Observational Study |
Unknown status |
NCT03226665 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Heavy mineral oil
Mineral Oil
Mineral Oil, Light
|
MINERAL OIL,EXTRA HEAVY
MINERAL OIL,MEDIUM
MINERAL OIL,REFINED
|
|